Evidence map›Paper›PMID 31170984›Full record

ReviewMalaria journal2019

Setting the scene and generating evidence for malaria elimination in Southern Mozambique.

Pedro Aide, Baltazar Candrinho, Beatriz Galatas, Khátia Munguambe, Caterina Guinovart, Fabião Luis, Alfredo Mayor, Krijn Paaijmans, Lucía Fernández-Montoya, Laia Cirera and 9 more

Open access · goldAbstract readReview
In one paragraph

Review in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Mass drug administration for malaria.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. BMJ open · 2024
    Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Pedro AideCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique. Pedro.aide@manhica.net.ORCID http://orcid.org/0000-0002-2379-6529
Baltazar CandrinhoNational Malaria Control Programme, Ministry of Health, Maputo, Mozambique.
Beatriz GalatasCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Khátia MunguambeCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Caterina GuinovartISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Fabião LuisCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Alfredo MayorCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Krijn PaaijmansCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Lucía Fernández-MontoyaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Laia CireraISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Quique BassatCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Sonia MocumbiCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Clara MenéndezCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Delino NhalungoCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Ariel NhacoloCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Regina RabinovichISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Eusébio MaceteCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Pedro AlonsoCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Francisco SaúteCentro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Manhiça Health Research Centre · MZBarcelona Institute for Global Health · ESEduardo Mondlane University · MZHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESMinistry of Health · MZ

Funding

Bill & Melinda Gates Foundation OPP1115265"la Caixa" Foundation OPP1115265
6 · The paper itself

Abstract

Mozambique has historically been one of the countries with the highest malaria burden in the world. Starting in the 1960s, malaria control efforts were intensified in the southern region of the country, especially in Maputo city and Maputo province, to aid regional initiatives aimed to eliminate malaria in South Africa and eSwatini. Despite significant reductions in malaria prevalence, elimination was never achieved. Following the World Health Organization's renewed vision of a malaria-free-world, and considering the achievements from the past, the Mozambican National Malaria Control Programme (NMCP) embarked on the development and implementation of a strategic plan to accelerate from malaria control to malaria elimination in southern Mozambique. An initial partnership, supported by the Bill and Melinda Gates Foundation and the La Caixa Foundation, led to the creation of the Mozambican Alliance Towards the Elimination of Malaria (MALTEM) and the Malaria Technical and Advisory Committee (MTAC) to promote national ownership and partner coordination to work towards the goal of malaria elimination in local and cross-border initiatives. Surveillance systems to generate epidemiological and entomological intelligence to inform the malaria control strategies were strengthened, and an impact and feasibility assessment of various interventions aimed to interrupt malaria transmission were conducted in Magude district (Maputo Province) through the "Magude Project". The primary aim of this project was to generate evidence to inform malaria elimination strategies for southern Mozambique. The goal of malaria elimination in areas of low transmission intensity is now included in the national malaria strategic plan for 2017-22 and the NMCP and its partners have started to work towards this goal while evidence continues to be generated to move the national elimination agenda forward.

Indexed as

Capital FinancingCommunicable Disease ControlDisease EradicationDisease Transmission, InfectiousHealth PolicyHumansMalariaMosquito ControlMozambiqueAllianceEliminationMagude projectMalariaMozambique

Identifiers

PMID31170984
PMCPMC6554892
OpenAlexW2948269729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.